BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32925090)

  • 1. Correlation Between Quantitative MRI and Muscle Histopathology in Muscle Biopsies from Healthy Controls and Patients with IBM, FSHD and OPMD.
    Lassche S; Küsters B; Heerschap A; Schyns MVP; Ottenheijm CAC; Voermans NC; van Engelen BGM
    J Neuromuscul Dis; 2020; 7(4):495-504. PubMed ID: 32925090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between muscle strength, histopathology, and magnetic resonance imaging in sporadic inclusion body myositis.
    Dahlbom K; Geijer M; Oldfors A; Lindberg C
    Acta Neurol Scand; 2019 Feb; 139(2):177-182. PubMed ID: 30347435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced specific force in patients with mild and severe facioscapulohumeral muscular dystrophy.
    Lassche S; Voermans NC; Schreuder T; Heerschap A; Küsters B; Ottenheijm CA; Hopman MT; van Engelen BG
    Muscle Nerve; 2021 Jan; 63(1):60-67. PubMed ID: 32959362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophy.
    Janssen BH; Pillen S; Voet NB; Heerschap A; van Engelen BG; van Alfen N
    Muscle Nerve; 2014 Dec; 50(6):968-75. PubMed ID: 24659533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological correlations and fat replacement imaging patterns in recessive limb-girdle muscular dystrophy type 12.
    De Wel B; Huysmans L; Depuydt CE; Goosens V; Peeters R; Santos FP; Thal DR; Dupont P; Maes F; Claeys KG
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1468-1481. PubMed ID: 37078404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging correlates with electrical impedance myography in facioscapulohumeral muscular dystrophy.
    Hamel J; Lee P; Glenn MD; Burka T; Choi IY; Friedman SD; Shaw DWW; McCalley A; Herbelin L; Dimachkie MM; Lemmers R; van der Maarel SM; Barohn RJ; Tawil R; Statland JM
    Muscle Nerve; 2020 May; 61(5):644-649. PubMed ID: 31884698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity.
    Banerji CRS; Henderson D; Tawil RN; Zammit PS
    Hum Mol Genet; 2020 Sep; 29(16):2746-2760. PubMed ID: 32744322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year follow-up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome.
    Vincenten SCC; Mul K; van As D; Jansen JJ; Heskamp L; Heerschap A; van Engelen BGM; Voermans NC
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1695-1706. PubMed ID: 37218549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding quantitative muscle MRI to the FSHD clinical trial toolbox.
    Mul K; Vincenten SCC; Voermans NC; Lemmers RJLF; van der Vliet PJ; van der Maarel SM; Padberg GW; Horlings CGC; van Engelen BGM
    Neurology; 2017 Nov; 89(20):2057-2065. PubMed ID: 29030457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.
    Kan HE; Scheenen TW; Wohlgemuth M; Klomp DW; van Loosbroek-Wagenmans I; Padberg GW; Heerschap A
    Neuromuscul Disord; 2009 May; 19(5):357-62. PubMed ID: 19329315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of pelvic girdle and proximal leg muscles in early oculopharyngeal muscular dystrophy.
    van der Sluijs BM; Lassche S; Knuiman GJ; Kusters B; Heerschap A; Hopman M; Schreuder TH; van Engelen BGM; Voermans NC
    Neuromuscul Disord; 2017 Dec; 27(12):1099-1105. PubMed ID: 29102430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.
    Janssen BH; Voet NB; Nabuurs CI; Kan HE; de Rooy JW; Geurts AC; Padberg GW; van Engelen BG; Heerschap A
    PLoS One; 2014; 9(1):e85416. PubMed ID: 24454861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies.
    Statland JM; Shah B; Henderson D; Van Der Maarel S; Tapscott SJ; Tawil R
    Muscle Nerve; 2015 Oct; 52(4):521-6. PubMed ID: 25704033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
    Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
    Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the burden of outpatient clinic and MRI-guided needle muscle biopsies as reported by patients with facioscapulohumeral muscular dystrophy.
    Kools J; Aerts W; Niks EH; Mul K; Pagan L; Maurits JSF; Thewissen R; van Engelen BG; Voermans NC
    Neuromuscul Disord; 2023 May; 33(5):440-446. PubMed ID: 37099913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative vs qualitative muscle MRI: Imaging biomarker in patients with Oculopharyngeal Muscular Dystrophy (OPMD).
    Melkus G; Sampaio ML; Smith IC; Rakhra KS; Bourque PR; Breiner A; Zwicker J; Lochmüller H; Brais B; Warman-Chardon J
    Neuromuscul Disord; 2023 Jan; 33(1):24-31. PubMed ID: 36462961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers.
    Mul K; Horlings CGC; Vincenten SCC; Voermans NC; van Engelen BGM; van Alfen N
    J Neurol; 2018 Nov; 265(11):2646-2655. PubMed ID: 30191320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers.
    van den Heuvel A; Lassche S; Mul K; Greco A; San León Granado D; Heerschap A; Küsters B; Tapscott SJ; Voermans NC; van Engelen BGM; van der Maarel SM
    Sci Rep; 2022 Jan; 12(1):1426. PubMed ID: 35082321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy.
    Alonso-Jimenez A; Kroon RHMJM; Alejaldre-Monforte A; Nuñez-Peralta C; Horlings CGC; van Engelen BGM; Olivé M; González L; Verges-Gil E; Paradas C; Márquez C; Garibaldi M; Gallano P; Rodriguez MJ; Gonzalez-Quereda L; Dominguez Gonzalez C; Vissing J; Fornander F; Eisum AV; García-Sobrino T; Pardo J; García-Figueiras R; Muelas N; Vilchez JJ; Kapetanovic S; Tasca G; Monforte M; Ricci E; Gomez MT; Bevilacqua JA; Diaz-Jara J; Zamorano II; Carlier RY; Laforet P; Pelayo-Negro A; Ramos-Fransi A; Martínez A; Marini-Bettolo C; Straub V; Gutiérrez G; Stojkovic T; Martín MA; Morís G; Fernández-Torrón R; Lopez De Munaín A; Cortes-Vicente E; Querol L; Rojas-García R; Illa I; Diaz-Manera J
    J Neurol Neurosurg Psychiatry; 2019 May; 90(5):576-585. PubMed ID: 30530568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leg Muscle Involvement in Facioscapulohumeral Muscular Dystrophy: Comparison between Facioscapulohumeral Muscular Dystrophy Types 1 and 2.
    Mair D; Huegens-Penzel M; Kress W; Roth C; Ferbert A
    Eur Neurol; 2017; 77(1-2):32-39. PubMed ID: 27855411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.